• Trade
  • Markets
  • Copy
  • Contests
  • News
  • 24/7
  • Calendar
  • Q&A
  • Chats
Trending
Screeners
SYMBOL
LAST
BID
ASK
HIGH
LOW
NET CHG.
%CHG.
SPREAD
SPX
S&P 500 Index
6870.39
6870.39
6870.39
6895.79
6858.28
+13.27
+ 0.19%
--
DJI
Dow Jones Industrial Average
47954.98
47954.98
47954.98
48133.54
47871.51
+104.05
+ 0.22%
--
IXIC
NASDAQ Composite Index
23578.12
23578.12
23578.12
23680.03
23506.00
+72.99
+ 0.31%
--
USDX
US Dollar Index
98.910
98.990
98.910
99.060
98.740
-0.070
-0.07%
--
EURUSD
Euro / US Dollar
1.16449
1.16458
1.16449
1.16715
1.16277
+0.00004
0.00%
--
GBPUSD
Pound Sterling / US Dollar
1.33339
1.33348
1.33339
1.33622
1.33159
+0.00068
+ 0.05%
--
XAUUSD
Gold / US Dollar
4200.66
4201.10
4200.66
4259.16
4194.54
-6.51
-0.15%
--
WTI
Light Sweet Crude Oil
59.940
59.970
59.940
60.236
59.187
+0.557
+ 0.94%
--

Community Accounts

Signal Accounts
--
Profit Accounts
--
Loss Accounts
--
View More

Become a signal provider

Sell trading signals to earn additional income

View More

Guide to Copy Trading

Get started with ease and confidence

View More

Signal Accounts for Members

All Signal Accounts

Best Return
  • Best Return
  • Best P/L
  • Best MDD
Past 1W
  • Past 1W
  • Past 1M
  • Past 1Y

All Contests

  • All
  • Trump Updates
  • Recommend
  • Stocks
  • Cryptocurrencies
  • Central Banks
  • Featured News
Top News Only
Share

US Stock Market Closing Report | On Friday (December 5), The Magnificent 7 Index Rose 0.17% To 208.74 Points, A Weekly Gain Of 0.82%. The "mega-cap" Tech Stock Index Rose 0.64% To 406.36 Points, A Weekly Gain Of 0.95%

Share

Citigroup's Stock Price Has Exceeded Its Book Value For The First Time Since 2018

Share

Brazil's Benchmark Stock Index Bovespa Closes Down 4.25%, Biggest Fall Since February 2021 - Preliminar Data

Share

The Nasdaq Golden Dragon China Index Closed Up 1.3% Initially, With A Cumulative Gain Of About 0.5% This Week, Achieving A V-shaped Reversal. Among Popular Chinese Concept Stocks, Baidu Closed Up 5.8%, GDS Holdings Rose 4.5%, XPeng Motors Rose 2.7%, New Oriental Education & Technology Group Rose 2.5%, While Pony.ai Fell 2.8% And Canadian Solar Fell 3.7%

Share

Argentina's Merval Index Closed Down 1.59%, Nearing 3.04 Million Points, But Rose 0.68% For The Week

Share

The 10-year US Treasury Yield Rose More Than 3 Basis Points On The Day Of The Pce Inflation Data Release, With A Cumulative Increase Of More Than 12 Basis Points This Week. On Friday (December 5th) In Late New York Trading, The Yield On The 10-year US Treasury Note Rose 3.69 Basis Points To 4.1351%, A Cumulative Increase Of 12.18 Basis Points This Week. The Yield On The 2-year US Treasury Note Rose 3.77 Basis Points To 3.5603%, A Cumulative Increase Of 7.10 Basis Points This Week; The Yield On The 30-year US Treasury Note Rose 3.41 Basis Points To 4.7888%. The Yield On The 10-year Treasury Inflation-Protected Securities (TPS) Rose 3.64 Basis Points To 1.8428%; The Yield On The 2-year TPS Rose 1.44 Basis Points To 1.0566%; And The Yield On The 30-year TPS Rose 3.59 Basis Points To 2.5663%

Share

Dallas Fed September Trimmed Mean Pce Price Index +1.9%

Share

Pentagon - State Department Approves Potential Sale Of Integrated Battle Command System And Equipment To Denmark For $3 Billion

Share

CFTC - CBOT Wheat Speculators Trim Net Short Position By 27782 Contracts To 77773 In Week To October 28

Share

CFTC - ICE Coffee Speculators Cut Net Long Position By 803 Contracts To 28613 In Week To October 28

Share

CFTC - Natural Gas Speculators In Four Major Nymex, ICE Markets Cut Net Long Position By 23064 Contracts To 181005 In Week To October 28

Share

CFTC - ICE Cocoa Speculators Trim Net Short Position By 2275 Contracts To 1316 In Week To October 28

Share

CFTC - ICE Cotton Speculators Trim Net Short Position By 5689 Contracts To 78918 In Week To October 28

Share

CFTC - Speculators Trim Corn Net Short Position

Share

CFTC - ICE Sugar Speculators Increase Net Short Position By 20188 Contracts To 187078 In Week To October 28

Share

CFTC - CBOT Soybean Speculators Switch To Net Long Position Of 73650 Contracts In Week To October 28, Adding 89,001

Share

CFTC - Speculators Increase CBOT US 2-Year Treasury Futures Net Short Position By 34053 Contracts To 1312,475 In Week On October 28

Share

CFTC - Oil Speculators Trim WTI Net Short Position By 33480 Contracts To 23660 In Week To October 28

Share

Committee On Homeland Security: Investigating Mobile Apps Hosted By Apple Enabling Users Anonymously Report, Track Federal Law Enforcement Movement

Share

CFTC - Comex Gold Speculators Raise Net Long Position By 13501 Contracts To 105635 In Week To October 28

TIME
ACT
FCST
PREV
Italy Retail Sales MoM (SA) (Oct)

A:--

F: --

P: --

Euro Zone Employment YoY (SA) (Q3)

A:--

F: --

P: --

Euro Zone GDP Final YoY (Q3)

A:--

F: --

P: --

Euro Zone GDP Final QoQ (Q3)

A:--

F: --

P: --

Euro Zone Employment Final QoQ (SA) (Q3)

A:--

F: --

P: --

Euro Zone Employment Final (SA) (Q3)

A:--

F: --

P: --
Brazil PPI MoM (Oct)

A:--

F: --

P: --

Mexico Consumer Confidence Index (Nov)

A:--

F: --

P: --

Canada Unemployment Rate (SA) (Nov)

A:--

F: --

P: --

Canada Labor Force Participation Rate (SA) (Nov)

A:--

F: --

P: --

Canada Employment (SA) (Nov)

A:--

F: --

P: --

Canada Part-Time Employment (SA) (Nov)

A:--

F: --

P: --

Canada Full-time Employment (SA) (Nov)

A:--

F: --

P: --

U.S. Personal Income MoM (Sept)

A:--

F: --

P: --

U.S. PCE Price Index YoY (SA) (Sept)

A:--

F: --

P: --

U.S. PCE Price Index MoM (Sept)

A:--

F: --

P: --

U.S. Personal Outlays MoM (SA) (Sept)

A:--

F: --

P: --

U.S. Core PCE Price Index MoM (Sept)

A:--

F: --

P: --

U.S. Core PCE Price Index YoY (Sept)

A:--

F: --

P: --

U.S. UMich 5-Year-Ahead Inflation Expectations Prelim YoY (Dec)

A:--

F: --

P: --

U.S. Real Personal Consumption Expenditures MoM (Sept)

A:--

F: --

P: --

U.S. 5-10 Year-Ahead Inflation Expectations (Dec)

A:--

F: --

P: --

U.S. UMich Current Economic Conditions Index Prelim (Dec)

A:--

F: --

P: --

U.S. UMich Consumer Sentiment Index Prelim (Dec)

A:--

F: --

P: --

U.S. UMich 1-Year-Ahead Inflation Expectations Prelim (Dec)

A:--

F: --

P: --

U.S. UMich Consumer Expectations Index Prelim (Dec)

A:--

F: --

P: --

U.S. Weekly Total Rig Count

A:--

F: --

P: --

U.S. Weekly Total Oil Rig Count

A:--

F: --

P: --

U.S. Unit Labor Cost Prelim (SA) (Q3)

--

F: --

P: --

U.S. Consumer Credit (SA) (Oct)

A:--

F: --

P: --

China, Mainland Foreign Exchange Reserves (Nov)

--

F: --

P: --

China, Mainland Exports YoY (USD) (Nov)

--

F: --

P: --

China, Mainland Imports YoY (CNH) (Nov)

--

F: --

P: --

China, Mainland Imports YoY (USD) (Nov)

--

F: --

P: --

China, Mainland Imports (CNH) (Nov)

--

F: --

P: --

China, Mainland Trade Balance (CNH) (Nov)

--

F: --

P: --

China, Mainland Exports (Nov)

--

F: --

P: --

Japan Wages MoM (Oct)

--

F: --

P: --

Japan Trade Balance (Oct)

--

F: --

P: --

Japan Nominal GDP Revised QoQ (Q3)

--

F: --

P: --

Japan Trade Balance (Customs Data) (SA) (Oct)

--

F: --

P: --

Japan GDP Annualized QoQ Revised (Q3)

--

F: --

P: --
China, Mainland Exports YoY (CNH) (Nov)

--

F: --

P: --

China, Mainland Trade Balance (USD) (Nov)

--

F: --

P: --

Germany Industrial Output MoM (SA) (Oct)

--

F: --

P: --

Euro Zone Sentix Investor Confidence Index (Dec)

--

F: --

P: --

Canada Leading Index MoM (Nov)

--

F: --

P: --

Canada National Economic Confidence Index

--

F: --

P: --

U.S. Dallas Fed PCE Price Index YoY (Sept)

--

F: --

P: --

U.S. 3-Year Note Auction Yield

--

F: --

P: --

U.K. BRC Overall Retail Sales YoY (Nov)

--

F: --

P: --

U.K. BRC Like-For-Like Retail Sales YoY (Nov)

--

F: --

P: --

Australia Overnight (Borrowing) Key Rate

--

F: --

P: --

RBA Rate Statement
RBA Press Conference
Germany Exports MoM (SA) (Oct)

--

F: --

P: --

U.S. NFIB Small Business Optimism Index (SA) (Nov)

--

F: --

P: --

Mexico Core CPI YoY (Nov)

--

F: --

P: --

Mexico 12-Month Inflation (CPI) (Nov)

--

F: --

P: --

Mexico PPI YoY (Nov)

--

F: --

P: --

Q&A with Experts
    • All
    • Chatrooms
    • Groups
    • Friends
    Connecting
    .
    .
    .
    Type here...
    Add Symbol or Code

      No matching data

      All
      Trump Updates
      Recommend
      Stocks
      Cryptocurrencies
      Central Banks
      Featured News
      • All
      • Russia-Ukraine Conflict
      • Middle East Flashpoint
      • All
      • Russia-Ukraine Conflict
      • Middle East Flashpoint
      Search
      Products

      Charts Free Forever

      Chats Q&A with Experts
      Screeners Economic Calendar Data Tools
      Membership Features
      Data Warehouse Market Trends Institutional Data Policy Rates Macro

      Market Trends

      Market Sentiment Order Book Forex Correlations

      Top Indicators

      Charts Free Forever
      Markets

      News

      News Analysis 24/7 Columns Education
      From Institutions From Analysts
      Topics Columnists

      Latest Views

      Latest Views

      Trending Topics

      Top Columnists

      Latest Update

      Signals

      Copy Rankings Latest Signals Become a signal provider AI Rating
      Contests
      Brokers

      Overview Brokers Assessment Rankings Regulators News Claims
      Broker listing Forex Brokers Comparison Tool Live Spread Comparison Scam
      Q&A Complaint Scam Alert Videos Tips to Detect Scam
      More

      Business
      Events
      Careers About Us Advertising Help Center

      White Label

      Data API

      Web Plug-ins

      Affiliate Program

      Awards Institution Evaluation IB Seminar Salon Event Exhibition
      Vietnam Thailand Singapore Dubai
      Fans Party Investment Sharing Session
      FastBull Summit BrokersView Expo
      Recent Searches
        Top Searches
          Markets
          News
          Analysis
          User
          24/7
          Economic Calendar
          Education
          Data
          • Names
          • Latest
          • Prev

          View All

          No data

          Scan to Download

          Faster Charts, Chat Faster!

          Download App
          English
          • English
          • Español
          • العربية
          • Bahasa Indonesia
          • Bahasa Melayu
          • Tiếng Việt
          • ภาษาไทย
          • Français
          • Italiano
          • Türkçe
          • Русский язык
          • 简中
          • 繁中
          Open Account
          Search
          Products
          Charts Free Forever
          Markets
          News
          Signals

          Copy Rankings Latest Signals Become a signal provider AI Rating
          Contests
          Brokers

          Overview Brokers Assessment Rankings Regulators News Claims
          Broker listing Forex Brokers Comparison Tool Live Spread Comparison Scam
          Q&A Complaint Scam Alert Videos Tips to Detect Scam
          More

          Business
          Events
          Careers About Us Advertising Help Center

          White Label

          Data API

          Web Plug-ins

          Affiliate Program

          Awards Institution Evaluation IB Seminar Salon Event Exhibition
          Vietnam Thailand Singapore Dubai
          Fans Party Investment Sharing Session
          FastBull Summit BrokersView Expo

          ARWR: Redemplo launch and pivotal 2026 data mark a transformative period for the pipeline

          Quartr
          Arrowhead Pharmaceuticals
          -4.99%

          Major milestones include the launch of Redemplo for FCS, with phase three studies in SHTG ongoing and key data readouts expected in 2026. The pipeline features innovative cardiometabolic and CNS programs, with a focus on expanding indications and market opportunities.

          Based on Arrowhead Pharmaceuticals, Inc. [ARWR] Evercore ISI 8th Annual HealthCONx Conference Audio Transcript — Dec. 4 2025

          Disclaimer
          This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
          Risk Warnings and Disclaimers
          You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.
          Add to Favorites
          Share

          Tesla, Netflix among market cap stock movers on Wednesday

          Investing.com
          POET Technologies
          -6.12%
          American Express
          -0.22%
          Anavex Life Sciences
          -0.34%
          Arrowhead Pharmaceuticals
          -4.99%
          American Eagle
          -4.51%

          Wednesday’s market has seen swings in various stocks based on news and other factors. Today, stocks like Tesla and Microchip Technology are rallying, while stocks like Pure Storage and Netflix are falling. Below are highlights of some of the biggest stock movers, from mega-caps to small caps.

          Mega-Cap Movers (Market Cap:$200 billion USD or higher)

          • Tesla Motors (TSLA); After AI Push, Trump Administration Is Now Looking To Robots; +3.97%
          • United Health Group (UNH) +4.49%
          • Goldman Sachs Group (GS) +2.34%
          • AbbVie Inc (ABBV) +2.3%
          • Wells Fargo (WFC); EquipmentShare secures $2.75 billion credit facility led by Wells Fargo; +2.86%
          • Oracle Corp (ORCL) +2.28%
          • American Express (AXP) +2.37%
          • McDonald’s (MCD) +2.45%
          • Micron Tech (MU); Micron to exit Crucial consumer business by February 2026; -2.97%
          • Netflix, Inc. (NFLX) -5.71%

          Large-Cap Stock Movers (Market Cap:$10-$200 billion USD)

          • Pure Storage Inc (PSTG); Pure Storage posts in-line Q3 earnings, revenue beat; -26.55%
          • SanDisk Corp-Exch (SNDK) -7.23%
          • UL Solutions (ULS); UL Solutions announces secondary offering of 12.5 million shares; -8.45%
          • Microchip Technology Inc (MCHP); Microchip raises quarterly guidance on strong bookings; +9.77%
          • ON Semiconductor (ON) +8.18%
          • Alcoa (AA) +7.86%
          • Dicks Sporting Goods Inc (DKS) +7.77%
          • Circle Internet Group Inc (CRCL) +7.58%
          • Amkor Technology (AMKR) +7.23%
          • Entegris Inc. (ENTG) +6.73%

          Mid-Cap Stock Movers (Market Cap:$2-$10 billion USD)

          • American Eagle Outfitters (AEO); American Eagle stock soars 11% on strong Q3 results, raised guidance; +13.95%
          • Sitime Corporation (SITM) +12.5%
          • Arrowhead Research Corp (ARWR) +11.93%
          • Alpha Metallurgical Resources (AMR) +11.73%
          • dMY Technology Group II (GENI) +11.28%
          • Beam Inc. (BEAM) +12.11%
          • MTech Acquisition A (ABTC) +9.46%
          • Reinvent Technology Partners Y (AUR) +10.4%
          • OneStream (OS); OneStream announces leadership changes to boost AI growth strategy; -9.71%
          • Gitlab (GTLB); GitLab appoints Jessica Ross as new CFO effective January 2026; -13.21%

          Small-Cap Stock Movers (Market Cap:$300 million - $2 billion USD)

          • MapLight Therapeutics Inc (MPLT) +29.67%
          • Ambitions Enterprise Management Co (AHMA) +25.71%
          • Anavex Life Sciences (AVXL) +22.62%
          • POET Tech NAQ (POET) +22.33%
          • InterPrivate Acquisition (AEVA); European automaker selects Aeva as exclusive lidar supplier; +21.26%
          • Fortrea Holdings (FTRE) +16.31%
          • Kestra Medical Technologies (KMTS); Kestra Medical Technologies prices upsized public offering at $23 per share; +13.99%
          • Anbio Biotechnology (NNNN) +13.36%
          • TryHard Holdings (THH) -26.14%
          • Adc Therapeutics SA (ADCT); ZYNLONTA-glofitamab combo shows 90% response rate in lymphoma trial; -28.48%

          For real-time, market-moving news, join Investing Pro.

          This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

          Risk Warnings and Disclaimers
          You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.
          Add to Favorites
          Share

          ARWR: Plozasiran launch, pipeline advances, and strong partnerships drive growth and innovation

          Quartr
          Arrowhead Pharmaceuticals
          -4.99%

          Major milestones include the approval and launch of Plozasiran for FCS, expansion into severe hypertriglyceridemia, and a robust pipeline in cardiometabolic, obesity, and CNS diseases. Strategic partnerships and strong cash reserves support growth and innovation.

          Based on Arrowhead Pharmaceuticals, Inc. [ARWR] Piper Sandler 37th Annual Healthcare Conference Audio Transcript — Dec. 3 2025

          Disclaimer
          This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
          Risk Warnings and Disclaimers
          You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.
          Add to Favorites
          Share

          ARWR: Plozasiran launch, pipeline innovation, and strategic deals drive growth and financial strength

          Quartr
          Arrowhead Pharmaceuticals
          -4.99%

          Major progress highlighted with the approval and launch of Plozasiran, targeting high-risk FCS and SHTG patients. Pipeline advances include dual dimer RNAi therapies, obesity and CNS programs, and strong partnerships with Sarepta and Novartis, supporting robust financial health.

          Based on Arrowhead Pharmaceuticals, Inc. [ARWR] Piper Sandler 37th Annual Healthcare Conference Audio Transcript — Dec. 3 2025

          Disclaimer
          This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
          Risk Warnings and Disclaimers
          You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.
          Add to Favorites
          Share

          Arrowhead Rises As Usa Fda Grants Breakthrough Tag For Rare Blood Fat Disorder Drug

          Reuters
          Arrowhead Pharmaceuticals
          -4.99%
          Risk Warnings and Disclaimers
          You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.
          Add to Favorites
          Share

          Arrowhead Gets FDA Breakthrough Therapy Designation for Severe Hypertriglyceridemia Drug

          Dow Jones Newswires
          Arrowhead Pharmaceuticals
          -4.99%

          By Nicholas G. Miller

          The Food and Drug Administration granted breakthrough therapy designation to Arrowhead Pharmaceuticals' plozasiran drug to treat severe hypertriglyceridemia.

          The designation expedites the development and review of drugs for which preliminary evidence indicates substantial improvement over available therapies to treat serious conditions.

          Arrowhead intends to complete phase three clinical trials of the drug in the middle of next year and submit a supplemental new drug application by the end of 2026.

          Write to Nicholas G. Miller at nicholas.miller@wsj.com.

          Risk Warnings and Disclaimers
          You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.
          Add to Favorites
          Share

          Dj Arrowhead Gets Fda Breakthrough Therapy Designation For Severe Hypertriglyceridemia Drug

          Reuters
          Arrowhead Pharmaceuticals
          -4.99%
          Risk Warnings and Disclaimers
          You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.
          Add to Favorites
          Share
          FastBull
          Copyright © 2025 FastBull Ltd

          728 RM B 7/F GEE LOK IND BLDG NO 34 HUNG TO RD KWUN TONG KLN HONG KONG

          TelegramInstagramTwitterfacebooklinkedin
          App Store Google Play Google Play
          Products
          Charts

          Chats

          Q&A with Experts
          Screeners
          Economic Calendar
          Data
          Tools
          Membership
          Features
          Function
          Markets
          Copy Trading
          Latest Signals
          Contests
          News
          Analysis
          24/7
          Columns
          Education
          Company
          Careers
          About Us
          Contact Us
          Advertising
          Help Center
          Feedback
          User Agreement
          Privacy Policy
          Business

          White Label

          Data API

          Web Plug-ins

          Poster Maker

          Affiliate Program

          Risk Disclosure

          The risk of loss in trading financial instruments such as stocks, FX, commodities, futures, bonds, ETFs and crypto can be substantial. You may sustain a total loss of the funds that you deposit with your broker. Therefore, you should carefully consider whether such trading is suitable for you in light of your circumstances and financial resources.

          No decision to invest should be made without thoroughly conducting due diligence by yourself or consulting with your financial advisors. Our web content might not suit you since we don't know your financial conditions and investment needs. Our financial information might have latency or contain inaccuracy, so you should be fully responsible for any of your trading and investment decisions. The company will not be responsible for your capital loss.

          Without getting permission from the website, you are not allowed to copy the website's graphics, texts, or trademarks. Intellectual property rights in the content or data incorporated into this website belong to its providers and exchange merchants.

          Not Logged In

          Log in to access more features

          FastBull Membership

          Not yet

          Purchase

          Become a signal provider
          Help Center
          Customer Service
          Dark Mode
          Price Up/Down Colors

          Log In

          Sign Up

          Position
          Layout
          Fullscreen
          Default to Chart
          The chart page opens by default when you visit fastbull.com